IL55109A - 1-acyl-2-cyanoaziridines,process for their preparation and pharmaceutical compositions containing them - Google Patents
1-acyl-2-cyanoaziridines,process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL55109A IL55109A IL55109A IL5510978A IL55109A IL 55109 A IL55109 A IL 55109A IL 55109 A IL55109 A IL 55109A IL 5510978 A IL5510978 A IL 5510978A IL 55109 A IL55109 A IL 55109A
- Authority
- IL
- Israel
- Prior art keywords
- cyanoaziridines
- acyl
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/16—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
- C07D203/18—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/22—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
- C07D203/24—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/564—Three-membered rings
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F42—AMMUNITION; BLASTING
- F42B—EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
- F42B3/00—Blasting cartridges, i.e. case and explosive
- F42B3/087—Flexible or deformable blasting cartridges, e.g. bags or hoses for slurries
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772731264 DE2731264A1 (de) | 1977-07-11 | 1977-07-11 | Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL55109A0 IL55109A0 (en) | 1978-09-29 |
| IL55109A true IL55109A (en) | 1982-07-30 |
Family
ID=6013651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL55109A IL55109A (en) | 1977-07-11 | 1978-07-09 | 1-acyl-2-cyanoaziridines,process for their preparation and pharmaceutical compositions containing them |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4267174A (de) |
| JP (1) | JPS5436254A (de) |
| AT (1) | AT356663B (de) |
| AU (2) | AU519219B2 (de) |
| BE (1) | BE868796A (de) |
| CA (1) | CA1086309A (de) |
| CS (1) | CS208656B2 (de) |
| DD (1) | DD137710A5 (de) |
| DE (1) | DE2731264A1 (de) |
| DK (1) | DK306978A (de) |
| ES (1) | ES471512A1 (de) |
| FI (1) | FI782157A (de) |
| FR (1) | FR2397403A1 (de) |
| GB (1) | GB1594079A (de) |
| HU (1) | HU179428B (de) |
| IL (1) | IL55109A (de) |
| IT (1) | IT1096910B (de) |
| LU (1) | LU79937A1 (de) |
| NL (1) | NL7807276A (de) |
| NO (1) | NO782399L (de) |
| NZ (1) | NZ187794A (de) |
| PL (1) | PL126639B1 (de) |
| PT (1) | PT68263A (de) |
| SE (1) | SE7807642L (de) |
| SU (1) | SU1077565A3 (de) |
| ZA (1) | ZA783829B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2906603A1 (de) | 1979-02-21 | 1980-09-04 | Boehringer Mannheim Gmbh | N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel |
| US4393000A (en) * | 1979-12-12 | 1983-07-12 | Mitsui Toatsu Chemicals, Inc. | Cyclization process for producing aziridine-2-carboxylic acid or its salts |
| US4925835A (en) * | 1986-05-01 | 1990-05-15 | Sloan-Kettering Institute For Cancer Research | Aziridinyl putrescine containing compositions and their uses in treating prostate cancer |
| US6982263B2 (en) * | 2001-06-08 | 2006-01-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Nitriles useful as reversible inhibitors of cysteine proteases |
| PL377847A1 (pl) * | 2003-01-14 | 2006-02-20 | Arena Pharmaceuticals Inc. | 1,2,3-Tripodstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie związanych z nim zaburzeń takich jak cukrzyca i hiperglikemia |
| EP1606282B1 (de) * | 2003-02-24 | 2008-11-12 | Arena Pharmaceuticals, Inc. | Phenyl- und pyridylpiperidinderivate als modulatoren des glucose-metabolismus |
| AR045047A1 (es) * | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| WO2005121121A2 (en) * | 2004-06-04 | 2005-12-22 | Arena Pharmaceuticals, Inc. | Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| DOP2006000010A (es) | 2005-01-10 | 2006-07-31 | Arena Pharm Inc | Procedimiento para preparar eteres aromáticos |
| MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| NZ565898A (en) * | 2005-09-16 | 2010-07-30 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| TW200811147A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| TW200811140A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| EP3378854B1 (de) | 2010-01-27 | 2022-12-21 | Arena Pharmaceuticals, Inc. | Verfahren zur herstellung von (r)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)essigsäure und salzen davon |
| BR112013008100A2 (pt) | 2010-09-22 | 2016-08-09 | Arena Pharm Inc | "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles." |
| AU2016205361C1 (en) | 2015-01-06 | 2021-04-08 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| SI3310760T1 (sl) | 2015-06-22 | 2023-02-28 | Arena Pharmaceuticals, Inc. | Kristalinična L-argininska sol (R)-2-(7-(4-ciklopentil-3-(trifluorometil)benziloksi)-1,2,3,4- tetrahidrociklo-penta(b)indol-3-il)ocetne kisline za uporabo pri motnjah, povezanih z receptorjem S1P1 |
| KR20190116416A (ko) | 2017-02-16 | 2019-10-14 | 아레나 파마슈티칼스, 인크. | 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법 |
| LV15518A (lv) * | 2019-02-18 | 2020-08-20 | Latvijas Organiskās Sintēzes Institūts | Aziridīn-2-karboksamīda atvasinājumi kā tioredoksīnreduktāzes inhibitori ar pretvēža un pretmetastatisku iedarbību un to sintēze |
| US20230069886A1 (en) * | 2020-01-10 | 2023-03-09 | Uniwersytet Jagiellonski | Aromatic sulphonamides derivatives that inhibits pdi a3, their synthesis and use |
| US20230039836A1 (en) * | 2020-01-10 | 2023-02-09 | Uniwersytet Jagiellonski | Aromatic sulphonamides derivatives that inhibits pdi a3, their synthesis and use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD110492A1 (de) * | 1974-03-21 | 1974-12-20 | ||
| JPS5932772B2 (ja) * | 1974-09-21 | 1984-08-10 | 旭光学工業 （株） | 照射光走査装置 |
| DE2528460A1 (de) * | 1975-06-26 | 1977-01-13 | Boehringer Mannheim Gmbh | Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans |
-
1977
- 1977-07-11 DE DE19772731264 patent/DE2731264A1/de not_active Withdrawn
-
1978
- 1978-05-17 GB GB20099/78A patent/GB1594079A/en not_active Expired
- 1978-06-16 US US05/916,389 patent/US4267174A/en not_active Expired - Lifetime
- 1978-07-04 FI FI782157A patent/FI782157A/fi not_active Application Discontinuation
- 1978-07-04 ZA ZA783829A patent/ZA783829B/xx unknown
- 1978-07-04 CA CA306,740A patent/CA1086309A/en not_active Expired
- 1978-07-04 SU SU782631500A patent/SU1077565A3/ru active
- 1978-07-05 NL NL7807276A patent/NL7807276A/xx not_active Application Discontinuation
- 1978-07-05 PL PL1978208195A patent/PL126639B1/pl unknown
- 1978-07-06 AU AU37826/78A patent/AU519219B2/en not_active Expired
- 1978-07-06 BE BE189121A patent/BE868796A/xx unknown
- 1978-07-06 AU AU37826/78A patent/AU3782678A/en active Granted
- 1978-07-06 DD DD78206567A patent/DD137710A5/de unknown
- 1978-07-06 ES ES471512A patent/ES471512A1/es not_active Expired
- 1978-07-07 NZ NZ187794A patent/NZ187794A/xx unknown
- 1978-07-07 SE SE7807642A patent/SE7807642L/xx unknown
- 1978-07-07 IT IT25474/78A patent/IT1096910B/it active
- 1978-07-07 LU LU79937A patent/LU79937A1/de unknown
- 1978-07-07 CS CS784544A patent/CS208656B2/cs unknown
- 1978-07-07 DK DK783069A patent/DK306978A/da not_active Application Discontinuation
- 1978-07-07 PT PT68263A patent/PT68263A/de unknown
- 1978-07-09 IL IL55109A patent/IL55109A/xx unknown
- 1978-07-10 HU HU78BO1723A patent/HU179428B/hu unknown
- 1978-07-10 FR FR7820468A patent/FR2397403A1/fr not_active Withdrawn
- 1978-07-10 NO NO782399A patent/NO782399L/no unknown
- 1978-07-10 AT AT496478A patent/AT356663B/de not_active IP Right Cessation
- 1978-07-11 JP JP8364578A patent/JPS5436254A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL55109A0 (en) | 1978-09-29 |
| IT1096910B (it) | 1985-08-26 |
| PL126639B1 (en) | 1983-08-31 |
| PT68263A (de) | 1978-08-01 |
| ES471512A1 (es) | 1979-10-01 |
| DE2731264A1 (de) | 1979-02-01 |
| DK306978A (da) | 1979-01-12 |
| NO782399L (no) | 1979-01-12 |
| ZA783829B (en) | 1980-03-26 |
| US4267174A (en) | 1981-05-12 |
| GB1594079A (en) | 1981-07-30 |
| NL7807276A (nl) | 1979-01-15 |
| AU519219B2 (en) | 1981-11-19 |
| BE868796A (fr) | 1979-01-08 |
| JPS5436254A (en) | 1979-03-16 |
| AU3782678A (en) | 1980-01-10 |
| NZ187794A (en) | 1980-05-08 |
| FI782157A (fi) | 1979-01-12 |
| LU79937A1 (de) | 1980-02-14 |
| FR2397403A1 (fr) | 1979-02-09 |
| SE7807642L (sv) | 1979-03-14 |
| ATA496478A (de) | 1979-10-15 |
| AU3782578A (en) | 1980-01-10 |
| IT7825474A0 (it) | 1978-07-07 |
| CS208656B2 (en) | 1981-09-15 |
| HU179428B (en) | 1982-10-28 |
| DD137710A5 (de) | 1979-09-19 |
| CA1086309A (en) | 1980-09-23 |
| SU1077565A3 (ru) | 1984-02-29 |
| PL208195A1 (de) | 1980-03-24 |
| AT356663B (de) | 1980-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2860900D1 (en) | Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them | |
| DE3064173D1 (en) | Novel 20-0-acylmaytansinoids, process for their preparation and pharmaceutical compositions containing them | |
| IL55109A0 (en) | 1-acyl-2-cyanoaziridines,process for their preparation and pharmaceutical compositions containing them | |
| DE2860893D1 (en) | Lipopeptides, process for their preparation and pharmaceutical compositions containing them | |
| DE2861361D1 (en) | 1-n-acylated-4-o-glycosyl-6-o-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them | |
| ZA781100B (en) | Pyrrolidine derivatives,process for their preparation and pharmaceutical compositions containing them | |
| ZA786054B (en) | Novel 6-oxy-genated-3,20-dioxo-pregnane-derivatives,process for the preparation thereof,and pharmaceutical compositions containing them | |
| IL55254A (en) | Bis-isoquinolinium compounds,their preparation and pharmaceutical compositions containing them | |
| IL53841A0 (en) | Isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them | |
| DE2861767D1 (en) | Cephalosprin derivatives, process for their preparation and pharmaceutical compositions containing them | |
| IL54111A (en) | 3,6-disubstituted-1,2,4-triazine-5-one-derivatives,process for their preparation and pharmaceutical compositions containing them | |
| IL53685A (en) | N2-arylsulfonyl-l-argininamides and the pharmaceutical salts thereof,process for their preparation and pharmaceutical compositions containing them | |
| DE2861177D1 (en) | 2-benzazepine compounds, processes for their preparation and pharmaceutical compositions containing them | |
| ZA782432B (en) | 2-benzyl-perhydroazepines,process for their preparation and pharmaceutical compositions containing them | |
| IL55139A (en) | Substituted 2-cyclopropyl-chromones,process for their preparation and pharmaceutical compositions containing them | |
| IL54899A (en) | Pyridazinylhydrazones,their preparation and pharmaceutical compositions containing them | |
| ZA784123B (en) | Imidazo-isoquinoline-diones,process for preparation and pharmaceutical compositions thereof | |
| DE2860212D1 (en) | 4-phenyl-8-amino-tetrahydroisoquinolines, pharmaceutical compositions containing them and process for preparation of these compositions | |
| IL54718A (en) | 17beta-hydroxy delta4-androsten-3-ones,process for their manufacture and pharmaceutical compositions containing them | |
| DE2861477D1 (en) | (omega-aminoalkoxy) bibenzyls, processes for their preparation and pharmaceutical compositions containing these substances | |
| IL52207A (en) | Substituted 2-vinyl-chromones, process for their preparation and pharmaceutical compositions containing them | |
| DE2860861D1 (en) | Piperazino-pyrrolobenzodiazepines, methods for their preparation and pharmaceutical compositions containing them | |
| GB2004885B (en) | Indolopyrones process for the preparation thereof and pharmaceutical compositions containing them | |
| IL54585A (en) | 5-sulfamoyl-orthanilic acids,process for their preparation and pharmaceutical compositions containing them | |
| IL55903A0 (en) | Isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them |